Luceome Biotechnologies

Luceome Biotechnologies, founded in Tucson, US, focuses on advancing drug discovery through innovative kinase assay services. Their core mission is to unravel biological mysteries and enable scientific discoveries by providing precise and reliable assay solutions. Utilizing their proprietary hybrid split-luciferase technology, Luceome offers both cell-based and cell-free kinase assays, catering to pharmaceutical companies and research institutions aiming to profile compound selectivity and efficacy.

Notable figures associated with Luceome Biotechnologies include experts in biochemistry and pharmacology who have contributed significantly to the development of their technology platform. The company has secured investments from key stakeholders in the biotech industry, which has facilitated its growth and innovation. Luceome's impact is evident in its contribution to drug discovery processes, providing critical data that accelerates the development of new therapeutics.